Xencor Inc reports results for the quarter ended March 31 - Earnings Summary

Xencor

08/05/2025 19:00

Xencor Inc XNCR.OQ reported a quarterly adjusted loss of 66 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-1.11.  The mean expectation of ten analysts for the quarter was for a loss of 60 cents per share. Wall Street expected results to range from -84 cents to -20 cents per share.

Revenue rose 155.6% to $32.73 million from a year ago; analysts expected $22.41 million.

Xencor Inc's reported EPS for the quarter was a loss of 66 cents​.

The company reported a quarterly loss of $48.42 million.

Xencor Inc shares had fallen by 25.0% this quarter and lost 65.3% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 27.1% in the last three months.​

In the last 30 days, four analysts negatively revised earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Xencor Inc is $31.00

This summary was machine generated from LSEG data May 8 at 06:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
-0.60
-0.66
Missed
Dec. 31 2024
-0.78
-0.62
Beat
Sep. 30 2024
-0.98
-0.71
Beat
Jun. 30 2024
-0.88
-1.07
Missed